Guidance
Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography.
Is this guidance up to date?
Next review: 2024
Guidance development process
How we develop NICE diagnostics guidance
This guidance replaces the NICE medtech innovation briefing on QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146).